Compound Radar

DaVita Inc. (DVA) Stock Analysis

Price $181.69
Market cap $11.66B
Next earnings Oct 29, 2026
Entry status Wait

Last updated Oct 27, 2026

Health Check

Last analyzed Oct 23, 2026

54
54/100 Acceptable
  • Financial Health 55
  • Profitability 60
  • Business Quality 60
  • Balance Sheet 40
  • Cash Flow 45

Why this rating?

Health 54/100 — Acceptable

Strongest Profitability 60/100
Softest Balance Sheet 40/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

DaVita Inc. (DVA) is a Medical Care Facilities company in the Healthcare sector. Compound Radar rates DaVita Inc. 54/100 (Acceptable) due to solid business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 15.35
  • Forward P/E 10.6
  • PEG 0.45
  • EV/Revenue 1.88

Profitability

  • Revenue Growth 5.2%
  • Gross Margin 32.4%
  • Operating Margin 16.1%
  • Net Margin 6.0%
  • ROE 88.5%

Financial strength

  • Cash $688.88M
  • Debt $13.41B
  • Net Cash $-12.72B
  • Free Cash Flow $1.31B
  • Current Ratio 1.47

Similar companies

Peers in Medical Care Facilities, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Care Facilities →

FAQ

How Compound Radar scores and tracks DaVita Inc. (DVA).

View Methodology & FAQ →